Last reviewed · How we verify
NCT05917847: DexAwake
Awake VDL Intubation With Dexmedetomidine, a Case Series (DexAwake)
trial testing Awake intubation in Awake Intubation in 24 participants. Completed in 30 June 2021.
1 July 2020
Quick facts
| Lead sponsor | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 1 January 2019 |
| Primary completion | 1 July 2020 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Awake intubation
Conditions studied
- Awake Intubation — all drugs for Awake Intubation →
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia — full company profile →
Who can join
Adults 18 to 99, any sex, with Awake Intubation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early after the videolaryngoscope'(VDL) introduction in clinical practice, the awake videolaryngoscopic (A-VDL) intubation took place with and instead of the awake video-bronchoscopic (A- VBS) intubation. The awake intubation is a safe profile technique that was underused since the only instrumentation available was the fiberoptic bronchoscope (FOB) or more recently the video-bronchoscope (VBS). With the VDL diffusion, the awake intubation option has eventually turned into a more utilized procedure, with the potential to become a daily procedure. This was also due to dexmedetomidine (DEX) introduction in The Operating Room pharmacopeia. Several steps must be standardized in order to homogeneously apply an awake intubation protocol. A department protocol is recommended (awake intubation guidelines) but a low threshold for enrollment can be used to shorten and standardize the execution times. This study aims to create a protocol and measure the outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05917847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia trials
Trials by the same sponsor.
- NCT06493708 — Effectiveness of EMDR in Borderline Personality Disorder · NA · recruiting
- NCT07370961 — Pilot Study to Evaluate the Impact of a Multidisciplinary Approach (Pharmacological and Psychological) in the Treatment · NA · completed
- NCT05847387 — The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study · recruiting
- NCT05738902 — Adherence and Compliance to ERAS in Gynecological Surgery · unknown
- NCT06765343 — Efficacy of Guided Biofilm Therapy in Pediatric Patient · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05917847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing